Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
26.8M
-
Shares change
-
-286K
-
Total reported value, excl. options
-
$213M
-
Value change
-
-$2.39M
-
Number of buys
-
49
-
Number of sells
-
-33
-
Price
-
$7.96
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q2 2020
100 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q2 2020.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.8M shares
of 37.4M outstanding shares and own 71.48% of the company stock.
Largest 10 shareholders include Russell Investments Group, Ltd. (3.03M shares), Legion Partners Asset Management, LLC (2.9M shares), WYNNEFIELD CAPITAL INC (2.88M shares), DIMENSIONAL FUND ADVISORS LP (2.34M shares), BlackRock Inc. (1.99M shares), VANGUARD GROUP INC (1.68M shares), HEARTLAND ADVISORS INC (1.23M shares), INVESTMENT COUNSELORS OF MARYLAND LLC (918K shares), NWQ INVESTMENT MANAGEMENT COMPANY, LLC (893K shares), and Pacific Ridge Capital Partners, LLC (615K shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.